OptiNose Inc has a consensus price target of $4.4, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Lake Street, HC Wainwright & Co., and HC Wainwright & Co. on March 18, 2024, March 18, 2024, and March 11, 2024. With an average price target of $4.67 between Lake Street, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 418.52% upside for OptiNose Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/18/2024 | OPTN | Buy Now | OptiNose | $0.90 | 344.44% | Lake Street | Thomas Flaten | $3 → $4 | Maintains | Buy | Get Alert |
03/18/2024 | OPTN | Buy Now | OptiNose | $0.90 | 455.56% | HC Wainwright & Co. | Matthew Caufield | → $5 | Reiterates | Buy → Buy | Get Alert |
03/11/2024 | OPTN | Buy Now | OptiNose | $0.90 | 455.56% | HC Wainwright & Co. | Matthew Caufield | → $5 | Initiates | → Buy | Get Alert |
08/21/2023 | OPTN | Buy Now | OptiNose | $0.90 | 233.33% | Lake Street | Thomas Flaten | → $3 | Initiates | → Buy | Get Alert |
08/11/2023 | OPTN | Buy Now | OptiNose | $0.90 | 233.33% | Piper Sandler | David Amsellem | $4 → $3 | Maintains | Overweight | Get Alert |
11/14/2022 | OPTN | Buy Now | OptiNose | $0.90 | 455.56% | BMO Capital | Gary Nachman | $6 → $5 | Maintains | Outperform | Get Alert |
10/21/2022 | OPTN | Buy Now | OptiNose | $0.90 | 455.56% | Jefferies | Glen Santangelo | → $5 | Assumes | → Buy | Get Alert |
The latest price target for OptiNose (NASDAQ: OPTN) was reported by Lake Street on March 18, 2024. The analyst firm set a price target for $4.00 expecting OPTN to rise to within 12 months (a possible 344.44% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for OptiNose (NASDAQ: OPTN) was provided by Lake Street, and OptiNose maintained their buy rating.
There is no last upgrade for OptiNose.
There is no last downgrade for OptiNose.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OptiNose, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OptiNose was filed on March 18, 2024 so you should expect the next rating to be made available sometime around March 18, 2025.
While ratings are subjective and will change, the latest OptiNose (OPTN) rating was a maintained with a price target of $3.00 to $4.00. The current price OptiNose (OPTN) is trading at is $0.90, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.